Demo corpus. Scores are computed on a select set of biomedical paper/datasets and may be inaccurate for papers outside this corpus — DataRank relies on network effects that improve with scale. We aim to expand this into a fully open resource pending additional funding.
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
Top 10%
14.0Top 10%
Open Access
8085 citations · base score 9.0
datarank_citation_only_1hop_v4Methodology
›Data sources & pipeline
Pipeline:CrossRefSciBERTdoi-metadataOpenAlexDataRank
Enrichment:Pending
FAIR ChecklistContext only (not used in score)
FFindable
Has DOI
AAccessible
Open Access
IInteroperable
RReusable
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
DataRank Breakdown
Base Component 10%Network Component 90%
Base Score Contribution
1.3
From this paper's citation signal
Citation Network Contribution
12.6
From 144 citing papers with measurable signal